Cargando…
Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer
PURPOSE: Epigenetic alterations of specific genes have recently been identified as diagnostic biomarkers for human cancers. However, there are currently no standardized epigenetic biomarkers for drug sensitivity in human gastrointestinal cancer. Therefore, the aim of this study is to identify a nove...
Autores principales: | Jeon, Mi-Seong, Song, Sang-Hyun, Yun, Jiyeon, Kang, Jee-Youn, Kim, Hwang-Phill, Han, Sae-Won, Kim, Tae-You |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843720/ https://www.ncbi.nlm.nih.gov/pubmed/26511811 http://dx.doi.org/10.4143/crt.2015.153 |
Ejemplares similares
-
Reduced cohesin destabilizes high-level gene amplification by disrupting pre-replication complex bindings in human cancers with chromosomal instability
por: Yun, Jiyeon, et al.
Publicado: (2016) -
Tissue Expression Of LPHN3 in Breast Cancer: An Immunohistochemistry Method
por: Kotepui, Kwuntida Uthaisar, et al.
Publicado: (2020) -
ADGRL3 (LPHN3) variants predict substance use disorder
por: Arcos-Burgos, Mauricio, et al.
Publicado: (2019) -
Crystal structure of LRG1 and the functional significance of LRG1 glycan for LPHN2 activation
por: Yang, Jimin, et al.
Publicado: (2023) -
LPHN2 inhibits vascular permeability by differential control of endothelial cell adhesion
por: Camillo, Chiara, et al.
Publicado: (2021)